Mallipathra Nutraceutical Private Limited
Produces and develops nutraceuticals and related services in India.
2016 | Bangaluru, Karnataka (India) | Active
Mallipathra Nutraceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Days
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 14.20%
- Profit Growth -53.62%
- Ebitda 10.04%
- Net Worth 4.87%
- Total Assets 69.36%
About Mallipathra Nutraceutical
Mallipathra Nutraceutical Private Limited (MNPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2016 (Nine years 8 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mousumi Mondal and Nori Radhika serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15400KA2016PTC086296
- Company No.
086296
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2016
- Date of AGM
08 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Food and Beverages
Who are the key members and board of directors at Mallipathra Nutraceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mousumi Mondal  | Director | 18-Feb-2016 | Current |
| Nori Radhika | Director | 18-Feb-2016 | Current |
Financial Performance of Mallipathra Nutraceutical.
Mallipathra Nutraceutical Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14.2% increase. The company also saw a substantial fall in profitability, with a 53.62% decrease in profit. The company's net worth moved up by a moderate rise of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mallipathra Nutraceutical?
In 2019, Mallipathra Nutraceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Someys Kitchen Private LimitedMousumi Mondal is a mutual person
- E-Kuhum Private Limited
Mousumi Mondal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mallipathra Nutraceutical?
Unlock and access historical data on people associated with Mallipathra Nutraceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mallipathra Nutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mallipathra Nutraceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.